Background and aim Existing real-time reverse transcriptase PCR (RT-qPCR) has certain
limitations for the point-of-care detection of severe acute respiratory syndrome coronavirus 2 …

Purpose Knowledge regarding patients' clinical condition at severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) detection is sparse. Data in the international …

Background The clinical manifestations and factors associated with the severity of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections outside of Wuhan are …

Objective To describe the characteristics of COVID-19 patients seen in March-April and June-
August 2020 in Marseille, France with the aim to investigate possible changes in the disease …

Background Until now, information on the spread of SARS-CoV-2 infections in Germany has
been based mainly on data from the public health offices. It may be assumed that these data …

Data regarding early predictors of clinical deterioration in patients with infection of severe
acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is still scarce. The aim of the …

Correct and reliable identification of SARS-CoV-2 in COVID-19 suspected patients is
essential for diagnosis. Respiratory samples should always be tested with real-time PCR for …

Purpose We aimed to further clarify the epidemiological and clinical characteristics of
asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …

Abstract From March 2, 2020, to April 26, 2020, 52,588 reverse transcription polymerase
chain reaction (RT-PCR) tests for severe acute respiratory syndrome coronavirus 2 (SARS …

Background There are few data on the full spectrum of disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection across the lifespan from …